Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 170.34 USD 0.42%
Market Cap: 19B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+1%
Revenue
Forecast
+13%
Operating Income
Forecast
+3%
Net Income
Forecast
+13%

Wall Street
Price Targets

DGX Price Targets Summary
Quest Diagnostics Inc

Wall Street analysts forecast DGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DGX is 188.3 USD with a low forecast of 160.28 USD and a high forecast of 210 USD.

DGX Lowest Forecast
Wall Street Target
160.28 USD
6% Downside
DGX Average Forecast
Wall Street Target
188.3 USD
11% Upside
DGX Highest Forecast
Wall Street Target
210 USD
23% Upside
Lowest
Price Target
160.28 USD
6% Downside
Average
Price Target
188.3 USD
11% Upside
Highest
Price Target
210 USD
23% Upside
Quest Diagnostics Inc Competitors:
Price Targets
A
AND
Andlauer Healthcare Group Inc
6% Upside
INNV
InnovAge Holding Corp
48% Upside
E
EHAB
Enhabit Inc
11% Downside
I
INFU
InfuSystem Holdings Inc
148% Upside
A
AND
Andlauer Healthcare Group Inc
6% Upside
INNV
InnovAge Holding Corp
48% Upside
E
EHAB
Enhabit Inc
11% Downside
I
INFU
InfuSystem Holdings Inc
148% Upside
EUDA
EUDA Health Holdings Ltd
67% Upside
CHE
Chemed Corp
23% Upside
T
TALK
Talkspace Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Quest Diagnostics Inc

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's revenue is 3%. The projected CAGR for the next 3 years is 6%.

3%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Quest Diagnostics Inc

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's operating income is 2%. The projected CAGR for the next 3 years is 12%.

2%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Quest Diagnostics Inc

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's net income is 4%. The projected CAGR for the next 3 years is 14%.

4%
Past Growth
14%
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
DGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DGX stock valuation using valuation multiples.
Wall Street Estimates
DGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DGX's stock price target?
Price Target
188.3 USD

According to Wall Street analysts, the average 1-year price target for DGX is 188.3 USD with a low forecast of 160.28 USD and a high forecast of 210 USD.

What is Quest Diagnostics Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's revenue is 3%. The projected CAGR for the next 3 years is 6%.

What is Quest Diagnostics Inc's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's operating income is 2%. The projected CAGR for the next 3 years is 12%.

What is Quest Diagnostics Inc's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Quest Diagnostics Inc's net income is 4%. The projected CAGR for the next 3 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.